BLCO vs. DHR: Which Stock Should Value Investors Buy Now?
BLCO vs. DHR: Which Stock Is the Better Value Option?
Here's Why Envista ( NVST ) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
A Look Into Danaher Inc's Price Over Earnings - Danaher ( NYSE:DHR )
In the current market session, Danaher Inc. ( NYSE: DHR ) price is at $183.36, after a 1.05% spike. However, over the past month, the stock fell by 10.91%, and in the past year, by 34.05%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is ...
Can Danaher's Diagnostics Unit Sustain Growth Amid Lower Sales in China?
DHR's Diagnostics unit posts steady Q2 growth, led by Beckman Coulter demand, while China headwinds weigh on results.
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation ...
DANAHER INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Danaher Corporation - DHR - Danaher ( NYSE:DHR )
NEW YORK and NEW ORLEANS, Sept. 17, 2025 ( GLOBE NEWSWIRE ) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ( "KSF" ) , announces that KSF has commenced an investigation into Danaher Corporation DHR.
Danaher's Life Sciences Segment Shrinks: What's the Path Forward?
DHR's Life Sciences unit faces revenue declines from weak demand, but new products and biotech advances offer growth potential.
myGwork's WorkFair 2025 Returns on 5 November with Global Job Opportunities for LGBTQ+ Students, Graduates, and Allies
LONDON, Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- myGwork, the leading global inclusive talent platform, is proud to announce the return of WorkFair on 5 November 2025. Powered by VFairs, this global virtual career event connects LGBTQ+ students, graduates, and allies with inclusive employers ...
Hologic's Breast Health Rebound in Motion: How to Play the Stock Now?
HOLX's Breast Health revival, fueled by AI, leadership shifts and product upgrades, is setting up a growth rebound.
Why Envista ( NVST ) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Danaher's Biotechnology Growth Picks Up: A Sign of More Upside?
DHR's Biotechnology unit grows 6% in Q2, driven by bioprocessing, despite weakness in research equipment demand.
Mueller Water Products Appoints Darin Harvey as Senior Vice President of Operations and Supply Chain - Mueller Water Products ( NYSE:MWA ) , Advanced Drainage Systems ( NYSE:WMS )
ATLANTA, Sept. 08, 2025 ( GLOBE NEWSWIRE ) -- Mueller Water Products, Inc. MWA, a leading manufacturer and marketer of products and solutions used in the transmission, distribution and measurement of water in North America, announced that it has named Darin Harvey as its Senior Vice President of ...
Mueller Water Products Appoints Darin Harvey as Senior Vice President of Operations and Supply Chain
ATLANTA, Sept. 08, 2025 ( GLOBE NEWSWIRE ) -- Mueller Water Products, Inc. ( NYSE: MWA ) , a leading manufacturer and marketer of products and solutions used in the transmission, distribution and measurement of water in North America, announced that it has named Darin Harvey as its Senior Vice ...
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR - Danaher ( NYSE:DHR )
NEW YORK, Sept. 07, 2025 ( GLOBE NEWSWIRE ) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation DHR.
Bio-Techne Stock Upgraded As Analyst Flags Attractive Entry Point - Bio-Techne ( NASDAQ:TECH )
RBC Capital upgraded Bio-Techne to Outperform and lifted its price target from $61 to $73. Bio-Techne shares are down 26% over the past year and 25% year-to-date. Get Discounted Real-Time Trade Alerts For a Volatile Market ( Labor Day Special )
Danaher Gains From Business Strength Amid Persisting Headwinds
DHR posts gains in bioprocessing, biotech and diagnostics, while life sciences softness and high debt weigh.
Why Is Teladoc ( TDOC ) Up 4.6% Since Last Earnings Report?
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
How Do Investors Really Feel About Danaher? - Danaher ( NYSE:DHR )
Danaher's DHR short percent of float has risen 12.03% since its last report. The company recently reported that it has 9.47 million shares sold short, which is 1.49% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.73 days to cover their ...
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Dan Loeb's Third Point Bets Big On AI, Tech With $442 Million Nvidia Stake-Exits Energy, Steel In Q2 Portfolio Overhaul - NVIDIA ( NASDAQ:NVDA )
Third Point LLC, the hedge fund led by billionaire investor Dan Loeb, has significantly reshaped its portfolio in the second quarter of 2025, doubling down on artificial intelligence and technology with a massive $442.37 million stake in Nvidia Corp., according to its latest 13F filing.
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today - Danaher ( NYSE:DHR )
Danaher DHR has outperformed the market over the past 10 years by 1.07% on an annualized basis producing an average annual return of 13.56%. Currently, Danaher has a market capitalization of $151.72 billion.
Danaher ( DHR ) Up 6.8% Since Last Earnings Report: Can It Continue?
Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Danaher ( DHR ) Just Overtook the 200-Day Moving Average
When a stock breaks out above the 200-day simple moving average, good things could be on the horizon. How should investors react?
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today - Danaher ( NYSE:DHR )
Danaher DHR has outperformed the market over the past 10 years by 1.23% on an annualized basis producing an average annual return of 13.19%. Currently, Danaher has a market capitalization of $149.65 billion.
iA Global Buys the Dip in Danaher's Stock Price
On Aug. 5, iA Global Asset Management Inc. disclosed buying 301,028 shares of Danaher ( NYSE:DHR ) , valued at approximately $58.43 million in Q2 2025.The investment firm bought 301,028 shares for $58.43 million in the quarter ended June 30.The transaction represented 0.88% of iA Global Asset ...
Why Envista ( NVST ) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
CVS or DHR: Which Is the Better Value Stock Right Now?
CVS vs. DHR: Which Stock Is the Better Value Option?
Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?
HOLX's Diagnostics arm eyes long-term growth with new assays, platform expansion and oncology test adoption despite headwinds.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Veralto ( VLTO ) is a Top-Ranked Momentum Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Danaher Stock Closes Near Day's High After Key Trading Signal - Danaher ( NYSE:DHR )
DHR reverses early down move after Alert Danaher Corp. DHR experienced a Power Inflow today, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions.
Markel's Q2 Earnings Surpass Estimates, Premiums Rise Y/Y
MKL tops Q2 earnings and revenue estimates, but profits dip as rising expenses weigh on margins.
Got $500? 3 Blue Chip Dividend Stocks to Buy and Hold Forever
Being a great investor doesn't have to be complicated or expensive.
International Markets and Danaher ( DHR ) : A Deep Dive for Investors
Explore how Danaher's (DHR) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today - Danaher ( NYSE:DHR )
Danaher DHR has outperformed the market over the past 10 years by 1.09% on an annualized basis producing an average annual return of 12.78%. Currently, Danaher has a market capitalization of $147.13 billion.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
CVS or DHR: Which Is the Better Value Stock Right Now?
CVS vs. DHR: Which Stock Is the Better Value Option?
Here's Why Danaher ( DHR ) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Danaher Raises 2025 Earnings Outlook
Danaher ( NYSE:DHR ) reported its second-quarter 2025 results on July 22, 2025, with sales of $5.9 billion and core revenue growth of 1.5% year over year. Adjusted diluted EPS grew 5% to $1.80, free cash flow hit $1.1 billion, and management raised full-year adjusted diluted net EPS guidance to ...
Danaher Beats Q2 Revenue, EPS Forecasts
Global science and technology innovator Danaher ( NYSE:DHR ) reported second quarter 2025 results on Tuesday, July 22, that topped analysts' consensus expectations. Q2 revenue of $5.94 billion came in above the $5.84 billion estimate, and adjusted EPS reached $1.80 versus the $1.64 analysts ...
Danaher Lifts 2025 Earnings Outlook Amid Biotech Growth, Cost Discipline - Danaher ( NYSE:DHR )
Danaher posted Q2 sales of $5.94 billion and EPS of $1.80, beating estimates of $5.84 billion and $1.64. Biotech sales rose to $1.85 billion with 6% core growth; profit margin hit 27.3% vs. 25.5% expected.
Danaher ( DHR ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Tuesday, July 22, 2025 at 8:00 a.m. ETPresident and Chief Executive Officer - Rainer BlairContinue reading ...
Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y
DHR tops Q2 estimates with strong sales across segments, lifting its 2025 EPS outlook amid mixed margin trends.
Danaher ( DHR ) Q2 Earnings and Revenues Top Estimates
Danaher (DHR) delivered earnings and revenue surprises of +9.76% and +1.71%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Danaher Gears Up to Post Q2 Earnings: What Lies Ahead for the Stock?
DHR's Q2 results are likely to reflect Life Sciences weakness, but strength in Biotechnology & Diagnostics units and Abcam acquisition add upside potential.
Danaher ( DHR ) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Evaluate the expected performance of Danaher (DHR) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Here's How Much a $1000 Investment in Agilent Technologies Made 10 Years Ago Would Be Worth Today
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
What Does the Market Think About Danaher? - Danaher ( NYSE:DHR )
Danaher's DHR short percent of float has risen 4.27% since its last report. The company recently reported that it has 7.75 million shares sold short, which is 1.22% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.19 days to cover their ...
Meta Platforms To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Tuesday - Abbott Laboratories ( NYSE:ABT ) , Danaher ( NYSE:DHR )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Evercore ISI Group slashed Danaher Corporation DHR price target from $230 to $226.
